Adavivint (SM04690) is a potent and selective small molecule inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM in a TCF/LEF reporter assay using SW480 cells. It is a valuable research tool for investigating Wnt pathway biology in vitro and has shown potential for modulating bone and cartilage regeneration in preclinical in vivo models.